The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.
Read more
An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.
Read more
A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction
Read more
Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.
Read more
A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.
Read more
A new study published in Scientific Reports this October suggests that the asthma treatments omalizumab, benralizumab and mepolizumab are linked to a higher risk of anaphylactic reactions than other similar drugs.
Read more
The European Academy of Allergy and Clinical Immunology (EAACI) launched their latest guidelines for diagnosing IgE-mediated food allergy this October.
Read more
A new patient information leaflet titled ‘Reducing the risk of your child having a serious allergic reaction.’ has been published by leading allergy experts including Anaphylaxis UK Clinical Panel members, Professor Adam…
Read more
The Royal Pharmaceutical Society (RPS) have said that millions of people may wrongly believe they are allergic to penicillin. The RPS, which represents pharmacists, suggests that up to 95% of these claims are incorrect.
Read more